A detailed history of Pittenger & Anderson Inc transactions in Amgen Inc stock. As of the latest transaction made, Pittenger & Anderson Inc holds 2,460 shares of AMGN stock, worth $776,228. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,460
Previous 2,460 -0.0%
Holding current value
$776,228
Previous $768,000 3.13%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023

SELL
$218.65 - $271.46 $65,595 - $81,438
-300 Reduced 10.87%
2,460 $661,000
Q2 2022

Jul 14, 2022

SELL
$230.71 - $256.74 $3,229 - $3,594
-14 Reduced 0.5%
2,760 $672,000
Q1 2022

Apr 28, 2022

SELL
$219.27 - $242.57 $340,087 - $376,226
-1,551 Reduced 35.86%
2,774 $671,000
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $6.76 Million - $7.73 Million
-33,982 Reduced 88.71%
4,325 $973,000
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $119,720 - $140,266
-564 Reduced 1.45%
38,307 $8.15 Million
Q2 2021

Aug 13, 2021

BUY
$233.58 - $259.14 $65,635 - $72,818
281 Added 0.73%
38,871 $9.48 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $588,505 - $685,807
2,652 Added 7.38%
38,590 $9.6 Million
Q4 2020

Feb 11, 2021

BUY
$216.38 - $257.67 $88,932 - $105,902
411 Added 1.16%
35,938 $8.26 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $127,414 - $141,695
543 Added 1.55%
35,527 $9.03 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $72,596 - $89,085
367 Added 1.06%
34,984 $8.25 Million
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $65,970 - $87,495
362 Added 1.06%
34,617 $7.02 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $22,137 - $28,454
-117 Reduced 0.34%
34,255 $8.26 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $36,040 - $43,184
-207 Reduced 0.6%
34,372 $6.65 Million
Q2 2019

Aug 09, 2019

BUY
$166.7 - $195.41 $395,079 - $463,121
2,370 Added 7.36%
34,579 $6.37 Million
Q1 2019

May 10, 2019

BUY
$180.87 - $203.88 $118,831 - $133,949
657 Added 2.08%
32,209 $6.12 Million
Q4 2018

Feb 14, 2019

BUY
$178.4 - $208.25 $109,180 - $127,449
612 Added 1.98%
31,552 $6.14 Million
Q3 2018

Oct 12, 2018

BUY
$185.29 - $208.89 $166,761 - $188,001
900 Added 3.0%
30,940 $6.41 Million
Q2 2018

Aug 15, 2018

BUY
$166.05 - $186.51 $432,560 - $485,858
2,605 Added 9.5%
30,040 $5.55 Million
Q1 2018

May 08, 2018

BUY
$169.43 - $198.0 $686,530 - $802,296
4,052 Added 17.33%
27,435 $4.68 Million
Q4 2017

Feb 13, 2018

BUY
$168.79 - $188.59 $21,098 - $23,573
125 Added 0.54%
23,383 $4.07 Million
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $39,313 - $44,885
-235 Reduced 1.0%
23,258 $4.34 Million
Q2 2017

Aug 10, 2017

BUY
N/A
23,493
23,493 $4.05 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pittenger & Anderson Inc Portfolio

Follow Pittenger & Anderson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Pittenger & Anderson Inc with notifications on news.